Bydureon Bcise

Active Ingredient(s): Exenatide Synthetic
FDA Approved: * October 20, 2017
Pharm Company: * ASTRAZENECA AB
Category: Diabetes

Exenatide, sold under the brand name Byetta and Bydureon among others, is a medication used to treat diabetes mellitus type 2.[6] It is used together with diet, exercise, and potentially other antidiabetic medication.[6] It is a treatment option after metformin and sulfonylureas.[7] It is given by injection under the skin within an hour before the first and last meal of the day.[6] A once-weekly injection version is also availabl... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Bydureon Bcise 2 mg/.85ml Subcutaneous Injection, Suspension, Extended Release
NDC: 0310-6540
Astrazeneca Pharmaceuticals Lp

Related Brands

Drugs with the same active ingredients